NEW YORK (GenomeWeb) – Luminex reported after the close of the market on Monday that its third quarter revenues increased 7 percent year over year as the company beat Wall St. estimates on the top and bottom lines.

For the three months ended Sept. 30, the Austin, Texas-based molecular diagnostics firm logged $60.6 million in revenues compared to $56.7 million in Q3 2014. On average, analysts had expected revenues of $57.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.